MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

BACKGROUND: Emerging evidence suggests molecular and phenotypic association between treatment resistance and epithelial–mesenchymal transition (EMT) in cancer. Compared with the well-defined molecular events of miR-200a in EMT, the role of miR-200a in therapy resistance remains to be elucidated. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, San-Jian, Yang, Liu, Hong, Qi, Kuang, Xia-Ying, Di, Gen-Hong, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766993/
https://www.ncbi.nlm.nih.gov/pubmed/29329575
http://dx.doi.org/10.1186/s12885-017-3930-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766993/
https://www.ncbi.nlm.nih.gov/pubmed/29329575
http://dx.doi.org/10.1186/s12885-017-3930-0

Ejemplares similares